Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Glaxosmithkline (GSK) Share Price

Price 1,886.00p on 13-05-2026 at 16:15:00
Change -5.50p -0.29%
Buy 1,884.00p
Sell 1,883.50p
Last Trade: Unknown 195.00 at 1,886.00p
Day's Volume: 5,075,367
Last Close: 1,886.00p
Open: 1,886.00p
ISIN: GB00BN7SWP63
Day's Range 1,864.00p - 1,897.00p
52wk Range: 1,315.00p - 2,282.00p
Market Capitalisation: £75.72b
VWAP: 1,883.813p
Shares in Issue: 4.02b

Glaxosmithkline (GSK) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Unknown* 195 1,886.00p OTC Trade
17:10:13 - 13-May-26
Buy* 241 1,886.00p SI Trade
Negotiated Trade
16:49:29 - 13-May-26
Buy* 33 1,886.00p SI Trade
Negotiated Trade
16:49:29 - 13-May-26
Buy* 8,422 1,886.00p SI Trade
16:35:05 - 13-May-26
Buy* 606 1,886.00p SI Trade
16:35:05 - 13-May-26
Buy* 20,862 1,886.00p SI Trade
16:35:05 - 13-May-26
Buy* 2,194,768 1,886.00p Suspected BUY Trade
16:35:05 - 13-May-26
Buy* 1 1,884.00p SI Trade
16:29:57 - 13-May-26
Buy* 379 1,884.00p Automatic Execution
16:29:56 - 13-May-26
Buy* 1,203 1,883.50p Automatic Execution
16:29:56 - 13-May-26
See more Glaxosmithkline trades

Glaxosmithkline (GSK) Share Price History

Time period:
to
Date Open High Low Close Volume
12th May 2026 (Tue) 1,822.50 1,891.50 1,822.00 1,891.50 12,114,945
11th May 2026 (Mon) 1,858.00 1,870.00 1,841.00 1,844.50 9,313,260
8th May 2026 (Fri) 1,855.00 1,857.50 1,831.50 1,843.00 6,108,446
7th May 2026 (Thu) 1,878.00 1,886.50 1,855.50 1,858.50 14,942,427
6th May 2026 (Wed) 1,870.50 1,889.50 1,865.50 1,875.00 8,581,440
5th May 2026 (Tue) 1,891.00 1,896.00 1,845.50 1,857.00 7,777,805
4th May 2026 (Mon) 1,901.00 1,901.00 1,901.00 1,901.00 0
1st May 2026 (Fri) 1,928.00 1,928.50 1,892.50 1,901.00 4,930,028
30th Apr 2026 (Thu) 1,907.00 1,959.00 1,900.50 1,928.50 10,952,579
29th Apr 2026 (Wed) 2,050.00 2,051.00 1,850.50 1,918.00 14,905,155
28th Apr 2026 (Tue) 1,964.50 2,038.00 1,964.50 2,028.00 10,393,498
27th Apr 2026 (Mon) 2,018.00 2,023.00 1,999.50 2,016.00 10,818,753
24th Apr 2026 (Fri) 2,070.00 2,071.00 2,020.00 2,020.00 4,689,325
23rd Apr 2026 (Thu) 2,055.00 2,083.00 2,053.00 2,076.00 9,031,937
22nd Apr 2026 (Wed) 2,082.00 2,093.00 2,073.00 2,075.00 6,988,214
21st Apr 2026 (Tue) 2,124.00 2,130.00 2,071.00 2,082.00 5,986,607
20th Apr 2026 (Mon) 2,145.00 2,156.00 2,134.00 2,144.00 4,715,270
17th Apr 2026 (Fri) 2,122.00 2,144.00 2,115.00 2,144.00 5,135,113
16th Apr 2026 (Thu) 2,121.00 2,135.00 2,115.00 2,123.00 4,358,573
15th Apr 2026 (Wed) 2,198.00 2,202.00 2,131.00 2,131.00 6,008,590
14th Apr 2026 (Tue) 2,170.00 2,195.00 2,164.00 2,190.00 4,785,341
13th Apr 2026 (Mon) 2,151.00 2,180.00 2,151.00 2,170.00 6,947,099
See more Glaxosmithkline price history

Glaxosmithkline (GSK) Regulatory News

Date Source Headline
11th May 2026 3:30 pm RNS Director/PDMR Shareholding
11th May 2026 7:05 am RNS Collaboration with CTTQ for bepirovirsen
11th May 2026 7:00 am RNS GSK - final tranche of share buyback programme
6th May 2026 6:22 pm RNS Result of AGM
5th May 2026 3:30 pm RNS Director/PDMR Shareholding
1st May 2026 3:00 pm RNS Holding(s) in Company
1st May 2026 3:00 pm RNS Total Voting Rights
29th Apr 2026 3:30 pm RNS Director/PDMR Shareholding
29th Apr 2026 7:00 am RNS 1st Quarter Results
28th Apr 2026 3:30 pm RNS Director/PDMR Shareholding
See more Glaxosmithkline regulatory news

Glaxosmithkline (GSK) Share News

GSK agrees China hepatitis B deal as kicks off last tranche of buyback

11th May 2026 08:26

(Alliance News) - GSK PLC on Monday launched the fifth tranche of its GBP2.0 billion buyback as it announced an exclusive collaboration with China pharmaceutical group Sino Biopharmaceutical Ltd. Read More

LONDON BRIEFING: Compass lifts outlook as GSK expands in China

11th May 2026 07:56

(Alliance News) - Compass Group raised annual profit guidance after reporting double-digit first-half operating profit growth, while GSK announced a China partnership for hepatitis B treatment bepirovirsen and the final tranche of its GBP2 billion buyback. Elsewhere, Victrex warned higher energy costs linked to the Middle East conflict could weigh on demand as interim profit declined. Read More

UK dividends calendar - next 7 days

7th May 2026 14:14

Read More

LONDON BROKER RATINGS: Exane raises Spirax, UBS cuts Fermi

6th May 2026 09:28

(Alliance News) - The following London-listed shares received analyst recommendations on Wednesday morning and on Tuesday: Read More

LONDON BROKER RATINGS: Citi cuts United Utilities and Severn Trent

1st May 2026 09:05

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and on Thursday: Read More

See more Glaxosmithkline news
FTSE 100 Latest
Value10,325.35
Change60.03

Login to your account

Forgot Password?

Not Registered